High Versus Lower Intensity Surveillance Following Resection of Retroperitoneal Sarcoma

The SARveillance trial is an efficient, pragmatic, multi-centre, international, stratified, partially-randomised, patient-preference trial within a registry of high versus lower intensity radiological surveillance following primary resection of retroperitoneal, abdominal and pelvic soft tissue sarcoma. The trial design is stratified by sarcoma tumour grade (high/intermediate grade and low grade).

NCT Number	NCT06480396
Lead Sponsor	Fondazione IRCCS Istituto Nazionale dei Tumori, Milano Collaborators: University of Birmingham, University Hospital Birmingham NHS Foundation Trust, Royal Marsden NHS Foundation Trust, University Hospital Padova, Campus Bio-Medico University, The Netherlands Cancer Institute, KU Leuven, Heidelberg University, Dana-Farber/Brigham and Women's Cancer Center, Emory University, Mayo Clinic, Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, The Cleveland Clinic, M.D. Anderson Cancer Center, University of Southern California, Ohio State University, Ottawa Hospital Research Institute, McGill University, Peter MacCallum Cancer Centre, Australia, Royal Prince Alfred Hospital, Sydney, Australia
Conditions	Sarcoma,Soft Tissue, Sarcoma Retroperitoneal
Enrollment	584 participants
Start Date	2024-11
Primary Completion	2033-12 (estimated)
Study Completion	2033-12 (estimated)
Updated on ClinicalTrials.gov	2024-10-16